In this episode, we discuss semaglutides, more commonly referred to by their brand names (Wegovy, Ozempic, etc.) have grown significantly in popularity. Originally designed and intended for managing diabetes in a more efficient and effective manner, they have begun to be prescribed for weight loss and have been heralded as a miracle cure for obesity. As with all miracle cures, the other side isn't as glamorous as we'd like to think. This episode digs into the science, culture, and sociology (and of course the ethics) of this pharmaceutical marvel and what it means for future care providers.

AUDIO:

INTRO Song is This Science by Coma-Media

OUTRO Song is Screening by Coma-Media

ACKNOWLEDGEMENT:

The Prehealth Podcast at Penn State is a production of Prehealth Advising in the Eberly College of Science at The Pennsylvania State University. It is produced, edited, and promoted by the Prehealth Advising Team. The views, opinions, and advice shared during this podcast are that of the hosts and any guests only and do not necessarily reflect the best advice for every student, at every institution, or for every health profession. This is a non-profit podcast made for the purpose of better serving prehealth students across the university system.